Neuphoria Therapeutics Inc. (NEUP)
NASDAQ: NEUP · Real-Time Price · USD
4.570
+0.220 (5.06%)
At close: Jun 26, 2026, 4:00 PM EDT
4.566
-0.004 (-0.08%)
Pre-market: Jun 29, 2026, 5:15 AM EDT
Neuphoria Therapeutics Employees
As of June 30, 2025, Neuphoria Therapeutics had 8 total employees, including 7 full-time and 1 part-time employees. The number of employees did not change compared to the previous year.
Employees
8
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$2,178,892
Market Cap
24.70M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Jun 30, 2025 | 8 | 0 | - | 7 | 1 |
| Jun 30, 2024 | 8 | - | - | 8 | 0 |
Related Stocks
| Company Name | Employees |
|---|---|
| Pluri | 142 |
| IGC Pharma | 70 |
| Evaxion | 46 |
| Longeveron | 38 |
| Quantum BioPharma | 17 |
| NeuroSense Therapeutics | 17 |
| BriaCell Therapeutics | 16 |
| Serina Therapeutics | 16 |
NEUP News
- 2 days ago - Neuphoria Therapeutics confirms merger discussions with Scancell Holdings - TheFly
- 2 days ago - Neuphoria Responds to the announcement made by London-listed Scancell Holdings plc - GlobeNewsWire
- 6 weeks ago - Neuphoria Therapeutics downgraded to Neutral from Buy at H.C. Wainwright - TheFly
- 6 weeks ago - Neuphoria Therapeutics Quarterly report: Q3 2026 - Filings
- 4 months ago - Neuphoria Therapeutics Quarterly report: Q2 2026 - Filings
- 7 months ago - Neuphoria announces ISS recommends shareholders vote ‘FOR’ director nominees - TheFly
- 7 months ago - Leading Proxy Advisory Firm ISS Recommends that Shareholders Vote the WHITE Proxy Card FOR Both of Neuphoria's Director Nominees - GlobeNewsWire
- 7 months ago - Neuphoria Therapeutics Proxy statement: Proxy filing - Filings